Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open-label, Multicenter Phase 3 Study of the Contraceptive Efficacy, Safety and Tolerability of the AG200-15 Transdermal Contraceptive Delivery System (TCDS)

NCT02158572 is registered in ClinicalTrials.gov with Agile Therapeutics as lead sponsor.

NCT NCT02158572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02158572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open-label, Multicenter Phase 3 Study of the Contraceptive Efficacy, Safety and Tolerability of the AG200-15 Transdermal Contraceptive Delivery System (TCDS)
Lead sponsor
Agile Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2014
Completion date
November 30, 2016
Enrollment
2,032 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy